| Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
| contig01201 |
proteasome ( macropain) 26s non- 4 |
629 |
20 |
5.15E-103 |
98.05% |
4 |
C:cytosol; C:protein complex; P:fluid transport; F:protein binding |
|
|
| contig01202 |
proteasome ( macropain) 26s non- 4 |
1288 |
20 |
1.24E-157 |
91.50% |
4 |
C:cytosol; C:proteasome complex; P:fluid transport; F:protein binding |
|
|
| contig01203 |
proteasome subunit beta type-1-a |
1172 |
20 |
2.09E-54 |
95.85% |
5 |
C:proteasome core complex; F:protein binding; F:threonine-type endopeptidase activity; P:ubiquitin-dependent protein catabolic process; C:nucleus |
EC:3.4.25.0 |
|
| contig01204 |
---NA--- |
411 |
0 |
|
|
0 |
|
|
|
| contig01205 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
| contig01206 |
---NA--- |
529 |
0 |
|
|
0 |
|
|
|
| contig01207 |
---NA--- |
281 |
0 |
|
|
0 |
|
|
|
| contig01208 |
---NA--- |
779 |
0 |
|
|
0 |
|
|
|
| contig01209 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
| contig01210 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
| contig01211 |
transcription factor ram2 |
772 |
20 |
5.25E-46 |
86.95% |
5 |
C:cytoplasm; P:positive regulation of cell proliferation; F:protein binding; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
| contig01212 |
camp-regulated phosphoprotein 19 |
1440 |
20 |
4.77E-54 |
90.10% |
7 |
P:positive regulation of Ras protein signal transduction; P:positive regulation of glucose import; F:potassium channel regulator activity; F:receptor binding; P:positive regulation of gluconeogenesis; P:dopamine receptor signaling pathway; C:cytoplasm |
|
|
| contig01213 |
pdz and lim domain 1 |
1104 |
20 |
8.55E-95 |
80.55% |
8 |
C:cytoplasm; F:transcription coactivator activity; C:cytoskeleton; P:response to oxidative stress; P:regulation of transcription; P:zinc ion transport; C:transcription factor complex; F:zinc ion binding |
|
|
| contig01214 |
par-6 partitioning defective 6 homolog gamma |
615 |
17 |
7.49E-11 |
86.29% |
1 |
F:protein binding |
|
|
| contig01215 |
tumor protein p53 inducible protein 3 |
509 |
20 |
2.24E-15 |
70.40% |
2 |
F:binding; F:catalytic activity |
|
|
| contig01216 |
kti12 chromatin associated |
463 |
20 |
3.51E-39 |
77.25% |
1 |
F:ATP binding |
|
|
| contig01217 |
dead (asp-glu-ala-asp) box polypeptide 18 |
1170 |
20 |
0 |
97.25% |
3 |
F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity |
|
|
| contig01218 |
---NA--- |
233 |
0 |
|
|
0 |
|
|
|
| contig01219 |
u3 small nucleolar homolog |
1732 |
20 |
0 |
82.30% |
3 |
P:rRNA processing; C:cytoplasm; C:nucleus |
|
|
| contig01220 |
heavy subunit |
1169 |
20 |
1.06E-98 |
96.45% |
4 |
P:cellular iron ion homeostasis; F:ferric iron binding; F:ferroxidase activity; P:iron ion transport |
EC:1.16.3.1 |
|
| contig01221 |
natriuretic peptide receptor type-c |
405 |
20 |
3.58E-36 |
70.80% |
12 |
P:negative regulation of adenylate cyclase activity; P:pancreatic juice secretion; F:peptide hormone binding; C:integral to membrane; F:peptide receptor activity, G-protein coupled; P:regulation of blood pressure; C:extracellular space; C:membrane fraction; P:inhibition of adenylate cyclase activity by G-protein signaling pathway; F:natriuretic peptide receptor activity; F:protein homodimerization activity; P:activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger |
|
|
| contig01222 |
pci domain containing 2 |
265 |
20 |
5.57E-29 |
94.80% |
1 |
F:protein binding |
|
|
| contig01223 |
---NA--- |
287 |
0 |
|
|
0 |
|
|
|
| contig01224 |
thioesterase superfamily member 2 |
764 |
20 |
6.03E-55 |
89.80% |
2 |
F:hydrolase activity; C:mitochondrion |
|
|
| contig01225 |
fk506 binding protein 6 |
510 |
20 |
1.20E-64 |
77.20% |
7 |
P:spermatogenesis; P:protein folding; C:membrane fraction; F:FK506 binding; P:peptidyl-proline modification; C:cytosol; F:peptidyl-prolyl cis-trans isomerase activity |
EC:5.2.1.8 |
|
| contig01226 |
cyclin-dependent kinase 7 |
1475 |
20 |
1.21E-169 |
90.45% |
16 |
F:androgen receptor binding; P:DNA repair; P:meiosis; P:transcription initiation from RNA polymerase II promoter; P:positive regulation of transcription from RNA polymerase II promoter; F:RNA polymerase II carboxy-terminal domain kinase activity; F:protein C-terminus binding; P:cell division; F:ATP binding; F:cyclin-dependent protein kinase activity; F:transcription coactivator activity; P:regulation of cyclin-dependent protein kinase activity; P:cell proliferation; P:androgen receptor signaling pathway; C:nucleus; P:protein amino acid phosphorylation |
EC:2.7.11.23; EC:2.7.11.22 |
|
| contig01227 |
---NA--- |
860 |
0 |
|
|
0 |
|
|
|
| contig01228 |
metastasis associated 1 member 3 |
1275 |
20 |
2.45E-160 |
86.15% |
6 |
C:cytoplasm; F:sequence-specific DNA binding; F:transcription factor activity; C:nucleus; F:zinc ion binding; P:regulation of transcription, DNA-dependent |
|
|
| contig01229 |
chromosome 7 open reading frame 30 |
995 |
20 |
1.68E-75 |
80.55% |
0 |
|
|
|
| contig01230 |
---NA--- |
309 |
0 |
|
|
0 |
|
|
|
| contig01231 |
dynactin 2 |
536 |
20 |
1.08E-08 |
84.70% |
7 |
C:cytoplasm; C:dynein complex; C:dynactin complex; C:membrane attack complex; F:motor activity; P:establishment of nucleus localization; C:microtubule |
|
|
| contig01232 |
---NA--- |
403 |
0 |
|
|
0 |
|
|
|
| contig01233 |
mitochondrial carrier homolog 2 |
654 |
20 |
4.35E-79 |
86.90% |
4 |
C:mitochondrial inner membrane; C:integral to membrane; F:binding; P:transport |
|
|
| contig01234 |
protein c6orf203 |
975 |
20 |
3.30E-60 |
76.80% |
0 |
|
|
|
| contig01235 |
inosine triphosphate pyrophosphatase |
660 |
20 |
1.86E-101 |
90.85% |
4 |
F:nucleoside-triphosphate diphosphatase activity; P:nucleotide metabolic process; C:cytoplasm; F:magnesium ion binding |
EC:3.6.1.19 |
|
| contig01236 |
---NA--- |
490 |
0 |
|
|
0 |
|
|
|
| contig01237 |
domain containing 3 |
570 |
20 |
9.64E-12 |
91.65% |
2 |
F:F; P:P |
|
|
| contig01238 |
---NA--- |
442 |
0 |
|
|
0 |
|
|
|
| contig01239 |
mitochondrial ribosomal protein l16 |
346 |
20 |
2.36E-19 |
77.05% |
3 |
F:structural constituent of ribosome; P:translation; C:ribonucleoprotein complex |
EC:3.6.5.3 |
|
| contig01240 |
histone acetyltransferase 1 |
753 |
20 |
3.97E-27 |
84.20% |
7 |
C:cytoplasm; P:DNA packaging; F:protein binding; F:histone acetyltransferase activity; F:transaminase activity; P:internal protein amino acid acetylation; C:nucleus |
EC:2.3.1.48; EC:2.6.1.0 |
|
| contig01241 |
g patch domain and kow motifs |
720 |
20 |
1.04E-90 |
67.00% |
1 |
C:intracellular |
|
|
| contig01242 |
s100p binding protein |
1865 |
20 |
6.07E-23 |
49.85% |
3 |
F:F; F:calcium-dependent protein binding; C:nucleus |
|
|
| contig01243 |
---NA--- |
135 |
0 |
|
|
0 |
|
|
|
| contig01244 |
phosphoglycerate kinase 1 |
482 |
20 |
1.90E-67 |
92.20% |
7 |
C:soluble fraction; F:phosphoglycerate kinase activity; P:phosphorylation; F:ATP binding; P:glycolysis; P:response to hypoxia; C:cytosol |
EC:2.7.2.3 |
|
| contig01245 |
---NA--- |
290 |
0 |
|
|
0 |
|
|
|
| contig01246 |
atp h+ mitochondrial f1 delta subunit |
720 |
20 |
6.88E-34 |
87.65% |
6 |
C:proton-transporting ATP synthase complex, catalytic core F(1); C:mitochondrial proton-transporting ATP synthase complex; F:hydrogen ion transporting ATP synthase activity, rotational mechanism; P:ATP synthesis coupled proton transport; F:metal ion binding; F:proton-transporting ATPase activity, rotational mechanism |
EC:3.6.3.14 |
|
| contig01247 |
probable palmitoyltransferase zdhhc23 |
278 |
3 |
7.70E-15 |
79.00% |
2 |
F:metal ion binding; P:zinc ion transport |
|
|
| contig01248 |
---NA--- |
285 |
0 |
|
|
0 |
|
|
|
| contig01249 |
xoct-91 protein |
1915 |
20 |
1.11E-112 |
76.95% |
12 |
P:mesoderm development; P:morphogenesis of embryonic epithelium; P:embryonic pattern specification; P:dorsal/ventral pattern formation; P:brain development; F:sequence-specific DNA binding; F:transcription factor activity; P:transcription antitermination; P:endoderm formation; P:ectoderm development; P:positive regulation of transcription, DNA-dependent; C:nucleus |
|
|
| contig01250 |
barrier-to-autointegration factor |
477 |
20 |
3.43E-39 |
86.80% |
7 |
C:cytoplasm; P:regulation of viral reproduction; F:DNA binding; C:chromosome; C:nucleus; P:DNA integration; P:response to virus |
|
|
| contig01251 |
splicing factor subunit 1 |
638 |
20 |
1.49E-28 |
98.10% |
7 |
F:chromatin binding; ; C:spliceosomal complex; F:protein binding; C:nuclear speck; P:anterior/posterior pattern formation; P:nuclear mRNA splicing, via spliceosome |
|
|
| contig01252 |
phospholipase a1 member a |
955 |
20 |
4.48E-139 |
69.15% |
5 |
P:phosphatidylserine metabolic process; C:signal recognition particle, endoplasmic reticulum targeting; C:extracellular region; P:negative regulation of signal transduction; F:phospholipase A1 activity |
EC:3.6.5.4; EC:3.1.1.32 |
|
| contig01253 |
serine threonine kinase receptor associated protein |
1380 |
20 |
1.20E-123 |
87.40% |
9 |
P:negative regulation of transforming growth factor beta receptor signaling pathway; F:receptor activity; P:RNA splicing; P:negative regulation of transcription from RNA polymerase II promoter; F:receptor binding; C:spliceosomal complex; F:kinase activity; P:mRNA processing; C:cytoplasm |
|
|
| contig01254 |
histone deacetylase 1 |
134 |
20 |
2.32E-19 |
100.00% |
3 |
P:histone deacetylation; C:nucleus; F:histone deacetylase activity |
|
|
| contig01255 |
g-rich rna sequence binding factor 1 |
887 |
20 |
4.80E-44 |
56.20% |
2 |
F:binding; P:multicellular organismal development |
|
|
| contig01256 |
metaxin 1a |
357 |
3 |
7.02E-08 |
77.33% |
0 |
|
|
|
| contig01257 |
---NA--- |
360 |
0 |
|
|
0 |
|
|
|
| contig01258 |
---NA--- |
292 |
0 |
|
|
0 |
|
|
|
| contig01259 |
---NA--- |
428 |
0 |
|
|
0 |
|
|
|
| contig01260 |
hydroxyacyl-coenzyme a dehydrogenase 3-ketoacyl-coenzyme a thiolase enoyl-coenzyme a hydratase (trifunctional protein) alpha subunit |
453 |
20 |
2.90E-62 |
82.55% |
13 |
F:NAD or NADH binding; F:acetyl-CoA C-acetyltransferase activity; F:long-chain-enoyl-CoA hydratase activity; F:acyl-CoA binding; F:acetyl-CoA C-acyltransferase activity; C:mitochondrial inner membrane; C:fatty acid beta-oxidation multienzyme complex; P:response to bacterium; F:3-hydroxyacyl-CoA dehydrogenase activity; P:fatty acid beta-oxidation; P:response to drug; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; F:enoyl-CoA hydratase activity |
EC:2.3.1.9; EC:4.2.1.74; EC:2.3.1.16; EC:1.1.1.35; EC:1.1.1.211; EC:4.2.1.17 |
|
| contig01261 |
---NA--- |
611 |
0 |
|
|
0 |
|
|
|
| contig01262 |
phosphatidylinositol 4-kinase type ii |
430 |
20 |
4.53E-31 |
93.75% |
8 |
C:cytoplasm; C:integral to plasma membrane; F:obs-phosphatidylinositol 4-kinase activity; F:protein binding; C:membrane attack complex; C:membrane raft; F:magnesium ion binding; P:phosphatidylinositol biosynthetic process |
EC:2.7.1.67 |
|
| contig01263 |
zinc finger protein 451 |
421 |
20 |
1.79E-43 |
51.20% |
1 |
F:binding |
|
|
| contig01264 |
na+ k+ alpha 1 polypeptide |
1108 |
20 |
3.33E-139 |
97.40% |
23 |
P:otolith development; P:sodium ion transport; F:sodium:potassium-exchanging ATPase activity; P:sperm motility; F:potassium ion binding; P:brain development; P:potassium ion transport; F:monovalent inorganic cation transmembrane transporter activity; F:potassium channel inhibitor activity; F:ATP binding; P:embryonic heart tube development; C:membrane attack complex; F:magnesium ion binding; P:metabolic process; P:determination of left/right symmetry; P:regulation of cellular pH; P:embryonic body morphogenesis; P:cardiac cell differentiation; P:otic vesicle formation; P:midbrain-hindbrain boundary development; F:sodium ion binding; C:integral to plasma membrane; F:potassium channel activity |
EC:3.6.3.9 |
|
| contig01265 |
ran guanine nucleotide release factor |
438 |
20 |
2.53E-42 |
67.70% |
0 |
|
|
|
| contig01266 |
subfamily member 12 |
474 |
20 |
3.30E-74 |
85.00% |
4 |
P:protein folding; C:integral to membrane; F:unfolded protein binding; F:heat shock protein binding |
|
|
| contig01267 |
gamma-interferon-inducible lysosomal thiol reductase precursor |
1100 |
20 |
4.80E-98 |
68.85% |
0 |
|
|
|
| contig01268 |
---NA--- |
238 |
0 |
|
|
0 |
|
|
|
| contig01269 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
| contig01270 |
tbc1 domain member 9 (with gram domain) |
243 |
20 |
2.30E-35 |
83.25% |
4 |
C:intracellular; F:Rab GTPase activator activity; F:calcium ion binding; P:regulation of Rab GTPase activity |
|
|
| contig01271 |
---NA--- |
779 |
0 |
|
|
0 |
|
|
|
| contig01272 |
loc90379 protein |
396 |
19 |
1.20E-39 |
83.89% |
1 |
P:ubiquitin cycle |
|
|
| contig01273 |
cytochrome b |
1140 |
20 |
1.06E-180 |
94.75% |
6 |
F:oxidoreductase activity; F:iron ion binding; P:electron transport; P:transport; C:integral to membrane; C:mitochondrial respiratory chain |
|
|
| contig01274 |
dna directed rna polymerase ii polypeptide b |
423 |
20 |
7.68E-79 |
100.00% |
7 |
F:DNA-directed RNA polymerase activity; C:DNA-directed RNA polymerase II, core complex; F:DNA binding; F:protein binding; F:magnesium ion binding; F:zinc ion binding; P:transcription from RNA polymerase II promoter |
EC:2.7.7.6 |
|
| contig01275 |
ccr4-not transcription subunit 2 |
879 |
20 |
7.40E-122 |
98.00% |
3 |
F:transcription regulator activity; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
| contig01276 |
---NA--- |
443 |
0 |
|
|
0 |
|
|
|
| contig01277 |
---NA--- |
160 |
0 |
|
|
0 |
|
|
|
| contig01278 |
syf2 rna splicing factor ( cerevisiae) |
948 |
20 |
1.54E-99 |
90.55% |
4 |
P:mRNA processing; C:spliceosomal complex; P:RNA splicing; F:protein binding |
|
|
| contig01279 |
centromere kinetochore protein zw10 |
308 |
20 |
2.46E-37 |
85.65% |
15 |
P:meiosis; P:mitotic sister chromatid segregation; C:spindle pole; P:cell division; P:protein complex assembly; C:kinetochore; F:protein binding; P:ER to Golgi vesicle-mediated transport; C:kinetochore microtubule; P:regulation of exit from mitosis; P:mitotic cell cycle checkpoint; C:endoplasmic reticulum membrane; F:centromeric DNA binding; P:protein transport; C:nucleus |
|
|
| contig01280 |
myc-associated zinc finger partial |
363 |
1 |
1.50E-10 |
70.00% |
0 |
|
|
|
| contig01281 |
---NA--- |
678 |
0 |
|
|
0 |
|
|
|
| contig01282 |
---NA--- |
612 |
0 |
|
|
0 |
|
|
|
| contig01283 |
polypeptide 49kda |
384 |
20 |
2.62E-63 |
89.50% |
6 |
F:protein binding; P:transcription; F:DNA primase activity; F:zinc ion binding; C:alpha DNA polymerase:primase complex; P:DNA replication, synthesis of RNA primer |
|
|
| contig01284 |
---NA--- |
331 |
0 |
|
|
0 |
|
|
|
| contig01285 |
---NA--- |
673 |
0 |
|
|
0 |
|
|
|
| contig01286 |
processing of precursor ribonuclease p mrp subunit ( cerevisiae) |
591 |
20 |
2.48E-58 |
74.00% |
8 |
C:ribonuclease MRP complex; F:identical protein binding; F:RNA binding; C:nucleolar ribonuclease P complex; P:rRNA processing; F:ribonuclease P activity; P:tRNA processing; P:mRNA cleavage |
EC:3.1.26.5 |
|
| contig01287 |
polymerase i polypeptide e |
1498 |
20 |
4.36E-90 |
69.95% |
3 |
C:nucleolus; P:rRNA transcription; F:protein binding |
|
|
| contig01288 |
activin a type i |
252 |
20 |
4.03E-43 |
92.90% |
42 |
P:patterning of blood vessels; F:activin binding; F:manganese ion binding; P:protein amino acid phosphorylation; P:positive regulation of transcription; P:regulation of ossification; P:negative regulation of calcium-dependent cell-cell adhesion; P:acute inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:anterior/posterior pattern formation; P:embryonic caudal fin morphogenesis; P:determination of ventral identity; P:odontogenesis of dentine-containing tooth; P:embryonic hemopoiesis; P:cartilage development; P:neural crest cell migration; P:gastrulation with mouth forming second; P:embryonic heart tube development; F:activin receptor activity, type I; P:urogenital system development; P:heart looping; P:dorsal convergence; P:negative regulation of activin receptor signaling pathway; P:brain development; F:transforming growth factor beta binding; F:magnesium ion binding; P:germ cell development; P:G1/S transition of mitotic cell cycle; C:activin receptor complex; P:determination of left/right symmetry; C:apical part of cell; P:mesoderm formation; P:liver development; P:pharyngeal system development; F:ATP binding; P:smooth muscle cell differentiation; P:regulation of skeletal muscle tissue development; P:negative regulation of apoptosis; P:in utero embryonic development; P:regulation of BMP signaling pathway; F:SMAD binding; C:cell cortex |
|
|
| contig01289 |
piwi-like 1 |
792 |
20 |
5.05E-23 |
91.60% |
10 |
C:cytoplasm; P:spermatogenesis; C:nucleoplasm; P:germ-line stem cell maintenance; P:anatomical structure morphogenesis; F:protein binding; P:multicellular organismal development; F:single-stranded RNA binding; C:membrane; P:gene silencing by RNA |
|
|
| contig01290 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
| contig01291 |
canopy 2 homolog |
436 |
20 |
5.66E-34 |
78.25% |
8 |
C:extracellular space; C:integral to plasma membrane; P:fibroblast growth factor receptor signaling pathway; P:midbrain-hindbrain boundary development; F:protein binding; C:signal recognition particle, endoplasmic reticulum targeting; P:negative regulation of signal transduction; C:endoplasmic reticulum |
EC:3.6.5.4 |
|
| contig01292 |
wd repeat domain 74 |
337 |
20 |
4.64E-28 |
87.75% |
1 |
C:nucleus |
|
|
| contig01293 |
---NA--- |
405 |
0 |
|
|
0 |
|
|
|
| contig01294 |
---NA--- |
414 |
0 |
|
|
0 |
|
|
|
| contig01295 |
---NA--- |
665 |
0 |
|
|
0 |
|
|
|
| contig01296 |
c10orf78 protein |
1071 |
20 |
2.41E-30 |
70.30% |
2 |
P:P; C:C |
|
|
| contig01297 |
fast kinase domains 3 |
248 |
20 |
1.65E-25 |
68.70% |
2 |
F:ATP binding; F:protein kinase activity |
|
|
| contig01298 |
succinate- gdp- alpha subunit |
491 |
20 |
2.09E-68 |
96.30% |
6 |
F:succinate-CoA ligase (GDP-forming) activity; C:mitochondrial inner membrane; F:GTP binding; F:ATP citrate synthase activity; P:tricarboxylic acid cycle; F:succinate-CoA ligase (ADP-forming) activity |
EC:6.2.1.4; EC:2.3.3.8; EC:6.2.1.5 |
|
| contig01299 |
---NA--- |
726 |
0 |
|
|
0 |
|
|
|
| contig01300 |
nadh dehydrogenase flavoprotein 24kda |
425 |
20 |
9.09E-39 |
96.00% |
9 |
F:NAD or NADH binding; P:transport; F:2 iron, 2 sulfur cluster binding; F:NADH dehydrogenase (ubiquinone) activity; C:mitochondrial respiratory chain complex I; P:nervous system development; P:mitochondrial electron transport, NADH to ubiquinone; F:iron ion binding; P:electron transport |
EC:1.6.5.3 |
|
100 Rows returned.
Helpdesk 